Cencora, Inc. (COR) Price/FCF Ratio: 35.32
Is Cencora, Inc.’s Price/FCF ratio high or low?
Cencora, Inc.'s Price/FCF ratio of 35.32 is 98% above its 5-year average of 17.86, around the middle of its 5-year range (9.52–63.66).
13.37% above its 12-month average of 31.15.
COR Price/FCF Ratio Chart
COR Average Price/FCF Ratio Chart
COR Current vs Average Price/FCF Ratio Chart
COR Price/FCF Ratio Metrics
PRICE/FCF RATIO
35.32
PRICE/FCF RATIO AVG TTM
31.15
PRICE/FCF RATIO AVG 3Y
20.78
PRICE/FCF RATIO AVG 5Y
17.86
PRICE/FCF RATIO AVG 10Y
15.21
PRICE/FCF RATIO AVG 15Y
14.64
PRICE/FCF RATIO AVG 20Y
13.90
CURRENT VS TTM AVG
+13.37%
CURRENT VS 3Y AVG
+69.99%
CURRENT VS 5Y AVG
+97.78%
CURRENT VS 10Y AVG
+132.17%
CURRENT VS 15Y AVG
+141.18%
CURRENT VS 20Y AVG
+154.10%
COR Competitors' Price/FCF Ratio
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cencora, Inc. (COR) | $54.80B | 35.32 | 31.15 | 20.78 | 17.86 |
| Becton, Dickinson and Company (BDX) | $52.98B | 13.06 | 16.42 | 21.03 | 23.62 |
| Regeneron Pharmaceuticals, Inc. (REGN) | $63.06B | 15.87 | 18.45 | 23.54 | 21.55 |
| Humana Inc. (HUM) | $45.53B | 35.97 | 25.65 | 17.25 | 27.47 |
| IDEXX Laboratories, Inc. (IDXX) | $44.24B | 41.91 | 55.24 | 55.77 | 64.44 |
| Agilent Technologies, Inc. (A) | $36.67B | 29.36 | 33.01 | 28.84 | 32.17 |
| Zoetis Inc. (ZTS) | $33.36B | 15.74 | 25.41 | 39.21 | 45.55 |
| Centene Corporation (CNC) | $32.19B | 5.09 | 8.56 | 22.79 | 17.15 |
| Medline Inc. (MDLN) | $30.96B | 19.81 | 21.13 | 21.13 | 21.13 |
| Cigna Corporation (CI) | $78.83B | 10.28 | 12.88 | 11.50 | 11.57 |
Free Cash Flow Valuation
P/FCF Ratio
35.3
FCF Yield
2.83%
Cencora, Inc. Price/FCF Ratio Formula & Definition
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Cencora, Inc. Price/FCF Ratio FAQ
- What is the Price/FCF ratio for Cencora, Inc. (COR)?
- The Price/FCF ratio for COR stock is 35.32.
- Is Cencora, Inc.'s Price/FCF ratio high or low?
- Cencora, Inc.'s Price/FCF ratio of 35.32 is 98% above its 5-year average of 17.86, around the middle of its 5-year range (9.52–63.66).
- What is the TTM average Price/FCF ratio for Cencora, Inc. (COR)?
- The TTM average Price/FCF ratio for COR stock is 31.15.
- What is the 3Y average Price/FCF ratio for Cencora, Inc. (COR)?
- The 3Y average Price/FCF ratio for COR stock is 20.78.
- What is the 5Y average Price/FCF ratio for Cencora, Inc. (COR)?
- The 5Y average Price/FCF ratio for COR stock is 17.86.
- What is the 10Y average Price/FCF ratio for Cencora, Inc. (COR)?
- The 10Y average Price/FCF ratio for COR stock is 15.21.
- What is the 15Y average Price/FCF ratio for Cencora, Inc. (COR)?
- The 15Y average Price/FCF ratio for COR stock is 14.64.
- What is the 20Y average Price/FCF ratio for Cencora, Inc. (COR)?
- The 20Y average Price/FCF ratio for COR stock is 13.90.
Cencora, Inc. Price/FCF Ratio History
| DATE | PRICE/FCF RATIO |
|---|---|
| 2026-06-12 | 35.32 |
| 2026-06-11 | 35.30 |
| 2026-06-10 | 35.27 |
| 2026-06-09 | 35.06 |
| 2026-06-08 | 34.37 |
| 2026-06-05 | 34.49 |
| 2026-06-04 | 33.90 |
| 2026-06-03 | 33.06 |
| 2026-06-02 | 33.21 |
| 2026-06-01 | 33.19 |
| 2026-05-29 | 33.78 |
| 2026-05-28 | 33.57 |
| 2026-05-27 | 33.48 |
| 2026-05-26 | 33.96 |
| 2026-05-22 | 34.47 |
| 2026-05-21 | 33.29 |
| 2026-05-20 | 33.20 |
| 2026-05-19 | 33.38 |
| 2026-05-18 | 32.84 |
| 2026-05-15 | 32.32 |
| 2026-05-14 | 32.74 |
| 2026-05-13 | 32.06 |
| 2026-05-12 | 32.72 |
| 2026-05-11 | 32.57 |
| 2026-05-08 | 32.74 |
| 2026-05-07 | 32.06 |
| 2026-05-06 | 31.69 |
| 2026-05-05 | 16.56 |
| 2026-05-04 | 16.44 |
| 2026-05-01 | 16.46 |
| 2026-04-30 | 16.68 |
| 2026-04-29 | 16.86 |
| 2026-04-28 | 16.89 |
| 2026-04-27 | 16.79 |
| 2026-04-24 | 16.69 |
| 2026-04-23 | 16.86 |
| 2026-04-22 | 16.69 |
| 2026-04-21 | 16.91 |
| 2026-04-20 | 17.49 |
| 2026-04-17 | 17.74 |
| 2026-04-16 | 17.46 |
| 2026-04-15 | 17.20 |
| 2026-04-14 | 17.32 |
| 2026-04-13 | 17.28 |
| 2026-04-10 | 17.37 |
| 2026-04-09 | 17.46 |
| 2026-04-08 | 17.59 |
| 2026-04-07 | 17.37 |
| 2026-04-06 | 17.38 |
| 2026-04-02 | 17.59 |
| 2026-04-01 | 17.20 |
| 2026-03-31 | 17.01 |
| 2026-03-30 | 16.78 |
| 2026-03-27 | 16.92 |
| 2026-03-26 | 17.22 |
| 2026-03-25 | 17.60 |
| 2026-03-24 | 17.72 |
| 2026-03-23 | 17.36 |
| 2026-03-20 | 17.70 |
| 2026-03-19 | 17.96 |
| 2026-03-18 | 17.61 |
| 2026-03-17 | 18.12 |
| 2026-03-16 | 18.73 |
| 2026-03-13 | 18.95 |
| 2026-03-12 | 19.09 |
| 2026-03-11 | 18.97 |
| 2026-03-10 | 19.07 |
| 2026-03-09 | 19.59 |
| 2026-03-06 | 19.41 |
| 2026-03-05 | 19.45 |
| 2026-03-04 | 19.94 |
| 2026-03-03 | 20.11 |
| 2026-03-02 | 20.18 |
| 2026-02-27 | 20.15 |
| 2026-02-26 | 19.85 |
| 2026-02-25 | 19.66 |
| 2026-02-24 | 19.73 |
| 2026-02-23 | 19.82 |
| 2026-02-20 | 19.55 |
| 2026-02-19 | 19.44 |
| 2026-02-18 | 19.50 |
| 2026-02-17 | 19.49 |
| 2026-02-13 | 19.54 |
| 2026-02-12 | 19.01 |
| 2026-02-11 | 19.80 |
| 2026-02-10 | 19.49 |
| 2026-02-09 | 19.67 |
| 2026-02-06 | 19.45 |
| 2026-02-05 | 19.07 |
| 2026-02-04 | 17.87 |
| 2026-02-03 | 21.87 |
| 2026-02-02 | 21.98 |
| 2026-01-30 | 21.72 |
| 2026-01-29 | 21.29 |
| 2026-01-28 | 21.19 |
| 2026-01-27 | 21.53 |
| 2026-01-26 | 21.49 |
| 2026-01-23 | 21.37 |
| 2026-01-22 | 21.31 |
| 2026-01-21 | 21.27 |
| 2026-01-20 | 21.20 |
| 2026-01-16 | 21.45 |
| 2026-01-15 | 21.48 |
| 2026-01-14 | 21.16 |
| 2026-01-13 | 20.91 |
| 2026-01-12 | 20.69 |
| 2026-01-09 | 20.30 |
| 2026-01-08 | 20.30 |
| 2026-01-07 | 20.58 |
| 2026-01-06 | 20.93 |
| 2026-01-05 | 20.61 |
| 2026-01-02 | 20.49 |
| 2025-12-31 | 20.42 |
| 2025-12-30 | 20.56 |
| 2025-12-29 | 20.57 |
| 2025-12-26 | 20.62 |
| 2025-12-24 | 20.55 |
| 2025-12-23 | 20.59 |
| 2025-12-22 | 20.56 |
| 2025-12-19 | 20.61 |
| 2025-12-18 | 20.59 |
| 2025-12-17 | 20.73 |
| 2025-12-16 | 20.66 |
| 2025-12-15 | 21.18 |
| 2025-12-12 | 20.92 |
| 2025-12-11 | 20.83 |
| 2025-12-10 | 20.60 |
| 2025-12-09 | 20.39 |
| 2025-12-08 | 20.42 |
| 2025-12-05 | 20.54 |
| 2025-12-04 | 20.41 |
| 2025-12-03 | 20.27 |
| 2025-12-02 | 21.20 |
| 2025-12-01 | 21.77 |
| 2025-11-28 | 22.30 |
| 2025-11-26 | 22.28 |
| 2025-11-25 | 22.66 |
| 2025-11-24 | 63.66 |
| 2025-11-21 | 62.54 |
| 2025-11-20 | 61.92 |
| 2025-11-19 | 61.69 |
| 2025-11-18 | 61.85 |
| 2025-11-17 | 62.42 |
| 2025-11-14 | 61.90 |
| 2025-11-13 | 62.50 |
| 2025-11-12 | 62.15 |
| 2025-11-11 | 62.43 |
| 2025-11-10 | 62.36 |
| 2025-11-07 | 61.69 |
| 2025-11-06 | 61.61 |
| 2025-11-05 | 60.54 |
| 2025-11-04 | 58.92 |
| 2025-11-03 | 58.30 |
| 2025-10-31 | 57.77 |
| 2025-10-30 | 58.35 |
| 2025-10-29 | 56.98 |
| 2025-10-28 | 57.40 |
| 2025-10-27 | 57.47 |
| 2025-10-24 | 56.90 |
| 2025-10-23 | 56.19 |
| 2025-10-22 | 56.57 |
| 2025-10-21 | 56.23 |
| 2025-10-20 | 55.99 |
| 2025-10-17 | 55.53 |
| 2025-10-16 | 54.62 |
| 2025-10-15 | 54.66 |
| 2025-10-14 | 54.37 |
| 2025-10-13 | 54.21 |
| 2025-10-10 | 54.38 |
| 2025-10-09 | 53.72 |
| 2025-10-08 | 53.12 |
| 2025-10-07 | 52.79 |
| 2025-10-06 | 52.21 |
| 2025-10-03 | 51.78 |
| 2025-10-02 | 52.77 |
| 2025-10-01 | 53.32 |
| 2025-09-30 | 53.45 |
| 2025-09-29 | 52.68 |
| 2025-09-26 | 52.50 |
| 2025-09-25 | 51.10 |
| 2025-09-24 | 52.73 |
| 2025-09-23 | 51.72 |
| 2025-09-22 | 49.39 |
| 2025-09-19 | 49.60 |
| 2025-09-18 | 49.74 |
| 2025-09-17 | 49.44 |
| 2025-09-16 | 49.59 |
| 2025-09-15 | 49.83 |
| 2025-09-12 | 51.74 |
| 2025-09-11 | 51.78 |
| 2025-09-10 | 50.68 |
| 2025-09-09 | 51.08 |
| 2025-09-08 | 50.94 |
| 2025-09-05 | 50.02 |
| 2025-09-04 | 50.06 |
| 2025-09-03 | 50.47 |
| 2025-09-02 | 50.42 |
| 2025-08-29 | 49.87 |
| 2025-08-28 | 49.58 |
| 2025-08-27 | 49.69 |
| 2025-08-26 | 49.54 |
| 2025-08-25 | 49.30 |
| 2025-08-22 | 50.04 |
| 2025-08-21 | 51.86 |
| 2025-08-20 | 51.94 |
| 2025-08-19 | 50.40 |
| 2025-08-18 | 49.65 |
| 2025-08-15 | 50.08 |
| 2025-08-14 | 50.43 |
| 2025-08-13 | 49.77 |
| 2025-08-12 | 49.45 |
| 2025-08-11 | 49.71 |
| 2025-08-08 | 48.76 |
| 2025-08-07 | 47.61 |
| 2025-08-06 | 48.53 |
| 2025-08-05 | 15.95 |
| 2025-08-04 | 16.02 |
| 2025-08-01 | 15.73 |
| 2025-07-31 | 15.61 |
| 2025-07-30 | 15.92 |
| 2025-07-29 | 15.81 |
| 2025-07-28 | 15.62 |
| 2025-07-25 | 15.84 |
| 2025-07-24 | 15.85 |
| 2025-07-23 | 16.01 |
| 2025-07-22 | 15.99 |
| 2025-07-21 | 15.97 |
| 2025-07-18 | 15.98 |
| 2025-07-17 | 16.06 |
| 2025-07-16 | 16.25 |
| 2025-07-15 | 16.08 |
| 2025-07-14 | 16.21 |
| 2025-07-11 | 16.11 |
| 2025-07-10 | 16.22 |
| 2025-07-09 | 16.38 |
| 2025-07-08 | 16.26 |
| 2025-07-07 | 16.51 |
| 2025-07-03 | 16.16 |
| 2025-07-02 | 15.89 |
| 2025-07-01 | 16.12 |
| 2025-06-30 | 16.36 |
| 2025-06-27 | 16.34 |
| 2025-06-26 | 16.18 |
| 2025-06-25 | 15.95 |
| 2025-06-24 | 16.05 |
| 2025-06-23 | 16.00 |
| 2025-06-20 | 16.02 |
| 2025-06-18 | 16.19 |
| 2025-06-17 | 16.00 |
| 2025-06-16 | 15.96 |
| 2025-06-13 | 16.13 |
| 2025-06-12 | 16.10 |
| 2025-06-11 | 15.64 |
| 2025-06-10 | 15.51 |
| 2025-06-09 | 15.49 |
| 2025-06-06 | 15.77 |
| 2025-06-05 | 15.74 |
| 2025-06-04 | 15.77 |
| 2025-06-03 | 15.91 |
| 2025-06-02 | 15.94 |
Showing the most recent 260 of 4,850 data points. The chart above shows the full history.
Related Metrics
About Cencora, Inc.
Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Robert Mauch